Published in Ophthalmology on September 01, 1981
Increased procollagenase activating angiogenic factor in the vitreous humour of oxygen treated kittens. Br J Ophthalmol (1988) 0.86
Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci (1994) 10.46
Blood vessel formation: what is its molecular basis? Cell (1996) 5.54
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33
Pericytes in the microvasculature. Cardiovasc Res (1996) 3.95
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol (1987) 3.72
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A (1989) 3.65
Regulators of angiogenesis. Annu Rev Physiol (1991) 3.27
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95
Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol (1985) 2.91
Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res (1999) 2.79
The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem (1996) 2.58
Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol (2003) 2.57
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun (1993) 2.56
Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn (2001) 2.53
Vascular development: cellular and molecular regulation. FASEB J (1997) 2.35
Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol (1981) 2.34
Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett (1995) 2.31
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest (1989) 2.16
Penetrating ocular injuries. Types of injuries and visual results. Ophthalmology (1983) 2.15
Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol (1995) 2.03
Angiogenic activity from bovine retina: partial purification and characterization. Proc Natl Acad Sci U S A (1981) 1.94
Growth factors are released by mechanically wounded endothelial cells. J Cell Biol (1989) 1.92
Intraocular tamponade duration and success of macular hole surgery. Retina (1996) 1.91
Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol (1980) 1.87
Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A (1989) 1.87
The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology (1993) 1.82
Refractive changes after scleral buckling surgery. Arch Ophthalmol (1989) 1.81
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev (1996) 1.75
Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol (1989) 1.71
Blood vessel maturation: vascular development comes of age. J Clin Invest (1999) 1.70
Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities. J Cell Biol (1984) 1.69
Mechanisms of angiogenesis. Annu Rev Physiol (1987) 1.68
Vitrectomy for macular pucker. Ophthalmology (1984) 1.68
Culture of retinal capillary cells using selective growth media. Microvasc Res (1983) 1.67
Vitreous surgery for macular pucker. Am J Ophthalmol (1981) 1.63
Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology (1992) 1.63
Wnt signaling in the vasculature. Angiogenesis (2002) 1.62
Full-thickness macular hole formation in eyes with a pre-existing complete posterior vitreous detachment. Ophthalmology (1995) 1.60
Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology (1986) 1.58
TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis (2001) 1.56
Cell-cell interactions in vascular development. Curr Top Dev Biol (2001) 1.48
Endophthalmitis due to Propionibacterium acnes sequestered between IOL optic and posterior capsule. Ophthalmic Surg (1989) 1.48
Vitrectomy for idiopathic epiretinal membranes causing macular pucker. Br J Ophthalmol (1988) 1.47
Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS (1997) 1.46
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology (1987) 1.46
Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology (1989) 1.45
Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology (1989) 1.45
Assessment of vision in idiopathic macular holes with macular microperimetry using the scanning laser ophthalmoscope. Ophthalmology (1993) 1.44
Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology (1986) 1.44
Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology (1995) 1.42
Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol (1991) 1.42
What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci (2007) 1.42
Nuclear sclerosis after vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol (1988) 1.41
Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina (1990) 1.40
Characterization of vascular development in the mouse retina. Microvasc Res (1988) 1.37
Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology (1984) 1.32
Silicone oil in the treatment of complicated retinal detachments. Ophthalmology (1987) 1.30
Adult tissues contain chemoattractants for vascular endothelial cells. Nature (1980) 1.30
Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res (1999) 1.30
Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol (1985) 1.30
Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology (1987) 1.29
The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci (1986) 1.28
Surgical vitrectomy for pseudophakic malignant glaucoma. Am J Ophthalmol (1986) 1.27
Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology (1983) 1.26
Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol (1978) 1.25
Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol (1987) 1.24
Iatrogenic retinal breaks complicating pars plana vitrectomy. Ophthalmology (1990) 1.23
Retinal detachment after extracapsular cataract extraction with posterior chamber intraocular lens. Ophthalmology (1987) 1.23
Pars plana vitrectomy in the management of endogenous Candida endophthalmitis. Am J Ophthalmol (1976) 1.23
Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol (1988) 1.22
Vitrectomy techniques in the management of selected penetrating ocular injuries. Ophthalmology (1978) 1.21
Multivariate analysis of prognostic factors in penetrating ocular injuries. Am J Ophthalmol (1984) 1.20
Retinal detachment in highly myopic eyes due to macular holes and epiretinal traction. Retina (1990) 1.17
A clinical and histopathologic study of epiretinal membranes affecting the macula and removed by vitreous surgery. Trans Am Ophthalmol Soc (1982) 1.16
The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol (1974) 1.16
Prognostic indicators of success and failure in vitrectomy for diabetic retinopathy. Ophthalmology (1986) 1.14
Vitrectomy for impending idiopathic macular holes. Am J Ophthalmol (1988) 1.14
Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol (1985) 1.13
Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol (1980) 1.12
Hospitalization requirements after vitreoretinal surgery. Arch Ophthalmol (1988) 1.12